tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ACTU Stock Latest News

Actuate Therapeutics files $250M mixed securities shelf
The FlyActuate Therapeutics files $250M mixed securities shelf
6d ago
ACTU
Actuate Therapeutics initiated with a Buy at B. Riley
PremiumThe Fly
Actuate Therapeutics initiated with a Buy at B. Riley
13d ago
ACTU
Actuate Therapeutics, Inc.: Strategic Regulatory Advances and Promising Clinical Data Drive Buy Rating
PremiumRatings
Actuate Therapeutics, Inc.: Strategic Regulatory Advances and Promising Clinical Data Drive Buy Rating
21d ago
ACTU
Actuate, Incyte, University of Pittsburgh collaborate on elraglusib trial
PremiumThe Fly
Actuate, Incyte, University of Pittsburgh collaborate on elraglusib trial
1M ago
ACTU
INCY
Actuate Therapeutics files to sell 1.33M shares of common stock for holders
PremiumThe Fly
Actuate Therapeutics files to sell 1.33M shares of common stock for holders
1M ago
ACTU
Promising Clinical Developments and Valuation Support Buy Rating for Actuate Therapeutics
PremiumRatingsPromising Clinical Developments and Valuation Support Buy Rating for Actuate Therapeutics
2M ago
ACTU
Actuate Therapeutics announces end of Phase 1 portion of elraglusib study
Premium
The Fly
Actuate Therapeutics announces end of Phase 1 portion of elraglusib study
2M ago
ACTU
Actuate Therapeutics Secures $4.7M in Private Placement
Premium
Company Announcements
Actuate Therapeutics Secures $4.7M in Private Placement
2M ago
8K
ACTU
Actuate highlights results from subgroup analysis of Phase 2 elraglusib trial
PremiumThe Fly
Actuate highlights results from subgroup analysis of Phase 2 elraglusib trial
3M ago
ACTU
Actuate reports biomarker, machine learning data from Phase 2 elraglusib trial
PremiumThe Fly
Actuate reports biomarker, machine learning data from Phase 2 elraglusib trial
3M ago
ACTU
Actuate Therapeutics announces inclusion in Russell 3000, 2000 indexes
PremiumThe Fly
Actuate Therapeutics announces inclusion in Russell 3000, 2000 indexes
3M ago
ACTU
Actuate Therapeutics Hosts Key Opinion Leader Event
PremiumCompany Announcements
Actuate Therapeutics Hosts Key Opinion Leader Event
3M ago
8K
ACTU
Actuate Therapeutics shares highlights from KOL eventon elraglusib data
PremiumThe FlyActuate Therapeutics shares highlights from KOL eventon elraglusib data
3M ago
ACTU
Actuate Therapeutics Reports Positive Phase 2 Trial Results
Premium
Company Announcements
Actuate Therapeutics Reports Positive Phase 2 Trial Results
3M ago
8K
ACTU
Promising Clinical Trial Results Justify Buy Rating for Actuate Therapeutics’ Elraglusib
Premium
Ratings
Promising Clinical Trial Results Justify Buy Rating for Actuate Therapeutics’ Elraglusib
3M ago
ACTU
Actuate Therapeutics Elects Directors at Annual Meeting
PremiumCompany Announcements
Actuate Therapeutics Elects Directors at Annual Meeting
4M ago
8K
ACTU
Actuate Therapeutics to host KOL event on Phase 2 elraglusib data
PremiumThe Fly
Actuate Therapeutics to host KOL event on Phase 2 elraglusib data
4M ago
ACTU
Actuate Therapeutics Announces Positive Phase 2 Trial Results
PremiumCompany Announcements
Actuate Therapeutics Announces Positive Phase 2 Trial Results
4M ago
8K
ACTU
Actuate Therapeutics announces elraglusib combination met primary endpoints
PremiumThe Fly
Actuate Therapeutics announces elraglusib combination met primary endpoints
4M ago
ACTU
Craig-Hallum bullish on Actuate Therapeutics, initiates with a Buy
PremiumThe FlyCraig-Hallum bullish on Actuate Therapeutics, initiates with a Buy
5M ago
ACTU
Actuate Therapeutics initiated with a Buy at Craig-Hallum
Premium
The Fly
Actuate Therapeutics initiated with a Buy at Craig-Hallum
5M ago
ACTU
Actuate Therapeutics files to sell 3.9M shares of common stock for holders
Premium
The Fly
Actuate Therapeutics files to sell 3.9M shares of common stock for holders
5M ago
ACTU

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >